Why Is OCULAR THERAPEUTIX I (OCUL) Stock Up Today?

Ocular Therapeutix stock rose 7.12% to $10.76 on Friday, driven by a strong intraday performance and positive pre-market earnings results. The stock opened at $10.06 and surged to a session high of $11.84 within the first 30 minutes of trading. Despite a pullback to $9.80 shortly after the open, the stock ended the session near the upper end of its range. The move followed the company’s second-quarter earnings report, which beat both revenue and earnings estimates.

What Happened

Ocular Therapeutix reported second-quarter earnings of $0.35 per share, exceeding the estimated $0.40 loss per share. Revenue came in at $13.475 million, surpassing the projected $13.199 million. These results were cited as a catalyst for the morning’s upward momentum. Analysts from Chardan Capital and HC Wainwright & Co. also contributed to the positive backdrop by maintaining their Buy ratings and raising price targets to $23 and $25 respectively. The Fly noted the stock’s 10.4% gain earlier in the day, highlighting its strong performance among health care stocks.

What The Data Shows

The stock’s intraday volatility was significant, with a high of $11.84 and a low of $9.80. Volume reached 3.3 million shares by the session’s end, 1.2 times the 3-month daily average. The stock closed at $10.74, up from its opening price. Meanwhile, insider transactions over the past 90 days included five sell transactions totaling $360,000, with the most recent filing on June 5, 2026. The 52-week tape also showed one fresh 52-week low and six fresh 52-week highs on August 17, 2026.

What To Watch

Ocular Therapeutix does not have an upcoming earnings date scheduled. Investors should monitor the breadth of analyst coverage and any further developments in the company’s product pipeline or strategic initiatives.